In this episode of EyeCan, we explore the rapidly evolving landscape of Geographic Atrophy (GA), an advanced form of age-related macular degeneration that significantly impacts vision and quality of life. Long considered an area of unmet need in retinal care, GA management has entered a new era marked by meaningful therapeutic innovation in Canada.
This discussion highlights the most significant advancements in treatment, the integration of newly approved therapies into clinical practice, and how these developments are reshaping conversations between clinicians and patients. We also examine the realities of access and reimbursement across provinces, emerging innovations in imaging and diagnostic technology, and Canada’s role in advancing clinical research.
Finally, we look ahead to the future of GA care, exploring ongoing unmet needs and the innovations that offer hope for improved outcomes for patients nationwide.
With your host, Dr. Hady Saheb and guest Dr. Deepa Yoganathan.
Written and Directed by Kim Tytler.
Produced by John Allaire of Allaire Strategic Works.
The EyeCan Podcast is made possible by support from Astellas Pharma Canada and Johnson&Johnson Vision.
Comments about EyeCan? Contact communications@cos-sco.ca and we’ll get back to you soon! Listening to EyeCan counts for unaccredited MOC credits. You may claim 0.5 credits per hour under Section 2 (Individual Learning) as “Educational content review”, up to 30 credits per year.
Podden och tillhörande omslagsbild på den här sidan tillhör
Canadian Ophthalmological Society. Innehållet i podden är skapat av Canadian Ophthalmological Society och inte av,
eller tillsammans med, Poddtoppen.